APLS vs ETN · rev $1.00B vs P/E 39, rev $15.98B
Apellis Pharmaceuticals Inc (APLS) versus Eaton Corporation PLC (ETN) — a side-by-side from cached financials, not a winner call.
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
Eaton Corporation PLC (ETN) is a specialty industrial machinery company listed on US.
Latest reported APLS revenue for 2025-12-31 was $1.00B. Net income was $22.4M. Revenue was up 28.5% from 2024-12-31 to 2025-12-31. APLS currently screens at market cap $2.29B.
Latest reported ETN revenue for 2026-06-30 was $15.98B. Net income was $1.69B. ETN currently screens at market cap $153.74B and trailing P/E 38.7.
APLS currently screens at market cap $2.29B. ETN currently screens at market cap $153.74B and trailing P/E 38.7.
Not investment advice. Open the APLS and ETN stock pages for the full models.
Not investment advice.